On Friday 14th April 2023 UnitedHealth Group reported full year and fourth quarter 2022 results reflecting broad-based growth at Optum and UnitedHealthcare.
Revenues of $324.2 Billion Grew 13% Year-Over-Year, with Double-Digit Growth at both Optum and UnitedHealthcare
Cash Flows from Operations were $26.2 Billion or 1.3x Net Income
Full Year and Fourth Quarter Net Earnings were $21.18 and $5.03 Per Share
Full Year and Fourth Quarter Adjusted Net Earnings were $22.19 and $5.34 Per Share
UnitedHealth Group affirmed the 2023 growth and performance objectives established at its November 29th Investor Conference, including revenues of
357 billion to 
360 billion, net earnings of $23.15 to $23.65 per share, adjusted net earnings of $24.40 to $24.90 per share and cash flows from operations of 
27 billion to 
28 billion.
Revenues of $324.2 Billion Grew 13% Year-Over-Year, with Double-Digit Growth at both Optum and UnitedHealthcare
Cash Flows from Operations were $26.2 Billion or 1.3x Net Income
Full Year and Fourth Quarter Net Earnings were $21.18 and $5.03 Per Share
Full Year and Fourth Quarter Adjusted Net Earnings were $22.19 and $5.34 Per Share
UnitedHealth Group affirmed the 2023 growth and performance objectives established at its November 29th Investor Conference, including revenues of
357 billion to 360 billion, net earnings of $23.15 to $23.65 per share, adjusted net earnings of $24.40 to $24.90 per share and cash flows from operations of 27 billion to 28 billion.
Feragatname
Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, işlem veya diğer türden tavsiye veya tavsiyeler anlamına gelmez ve teşkil etmez. Kullanım Şartları'nda daha fazlasını okuyun.
Feragatname
Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, işlem veya diğer türden tavsiye veya tavsiyeler anlamına gelmez ve teşkil etmez. Kullanım Şartları'nda daha fazlasını okuyun.